Skip to content
Recall Observatory FDA recall evidence

Drug product

Solifenacin Succinate Tablets, 10 mg, packaged in a) 30-count bottles (NDC 51991-894-33) and b) 90-count bottles (NDC 51991-894-90), Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487; Manufactured by: Piramal Enterprises Limited Plot No 67-70, Sector -2 Pithampur 454 775, Dist, Dhar Madhya Pradesh, INDIA

D-1051-2020

January 24, 2020

Class II

Product summary

Firm
Breckenridge Pharmaceutical, Inc
Event
Event 85186
Status
Terminated
Classification
Class II
Quantity
11, 250 bottles
Official record key
drug-enforcement:D-1051-2020

Official wording

Reason: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.

Code information: Lot #: a) 81253, 81272, Exp. Date 01/2021 and b) 81268, Exp. Date 01/2021

Distribution pattern: Product was distributed nationwide within the United States.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations